Thermo Fisher Scientific TMO Life Sciences Solutions — Segment assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's life sciences solutions — segment assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Thermo Fisher Scientific's life sciences solutions — segment assets?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — segment assets of $3.49B in Q1 2026.
- How has Thermo Fisher Scientific's life sciences solutions — segment assets changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — segment assets increased by 15.6% year-over-year, from $3.02B to $3.49B.
- What does life sciences solutions — segment assets mean?
- This metric represents the total book value of assets specifically allocated to the Life Sciences Solutions operating segment. It encompasses the tangible and intangible resources, including manufacturing facilities, inventory, and intellectual property, utilized to support the development and distribution of life science reagents and instruments. Monitoring this asset base helps investors understand the capital intensity required to sustain the segment's revenue generation.